Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10533171 Oligonucleotide comprising an inosine for treating DMD

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
March 24, 2017
Date of Patent
January 14, 2020
Patent Application Number
15468239
Patent Citations Received
‌
US Patent 12128109 Muscle targeting complexes and formulations for treating dystrophinopathies
0
‌
US Patent 12005124 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 12012460 Muscle-targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide
0
‌
US Patent 11497815 Muscle targeting complexes and uses thereof for treating dystrophinopathies
‌
US Patent 11034956 Oligonucleotide comprising an inosine for treating DMD
‌
US Patent 11248056 Muscle targeting complexes and uses thereof for treating dystrophinopathies
‌
US Patent 11634714 Oligonucleotide comprising an inosine for treating DMD
0
‌
US Patent 11629197 Methods of using muscle targeting complexes to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy or a disease associated with muscle weakness
0
‌
US Patent 11633496 Muscle targeting complexes and uses thereof for treating dystrophinopathies
0
‌
US Patent 11679161 Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophy
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10533171
Patent Primary Examiner
‌
Kimberly Chong

Find more entities like US Patent 10533171 Oligonucleotide comprising an inosine for treating DMD

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo